From: Rationale for prostaglandin I2in bone marrow oedema – from theory to application
ARCO 0 | ARCO I | ARCO II | ARCO III | ARCO IV | |
---|---|---|---|---|---|
Femoral head (n = 42) | |||||
Before treatment | 0 | 20 | 12 | 9 | 1 |
Three months | 15 | 9 | 8 | 9 | 1 |
Six months | 18 | 8 | 6 | 9 | 1 |
Distal femur (n = 19) | |||||
Before treatment | 0 | 13 | 4 | 2 | 0 |
Three months | 10 | 4 | 3 | 2 | 0 |
Six months | 11 | 3 | 3 | 2 | 0 |
Proximal tibia (n = 18) | |||||
Before treatment | 0 | 14 | 2 | 2 | 0 |
Three months | 10 | 5 | 1 | 2 | 0 |
Six months | 13 | 2 | 1 | 2 | 0 |
Distal tibia (n = 7) | |||||
Before treatment | 0 | 6 | 1 | 0 | 0 |
Three months | 3 | 4 | 0 | 0 | 0 |
Six months | 3 | 4 | 0 | 0 | 0 |
Hindfoot (n = 21) | |||||
Before treatment | 0 | 21 | 0 | 0 | 0 |
Three months | 12 | 8 | 1 | 0 | 0 |
Six months | 14 | 5 | 2 | 0 | 0 |
Middlefoot (n = 7) | |||||
Before treatment | 0 | 7 | 0 | 0 | 0 |
Three months | 6 | 1 | 0 | 0 | 0 |
Six months | 6 | 1 | 0 | 0 | 0 |
Humerus (n = 3) | |||||
Before treatment | 0 | 1 | 1 | 0 | 1 |
Three months | 0 | 0 | 2 | 0 | 1 |
Six months | 0 | 0 | 2 | 0 | 1 |